Analyst Price Targets — EVFM
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 4, 2022 12:00 am | Jeffrey Hung | Morgan Stanley | $66.25 | $55.00 | Pulse 2.0 | Evofem Biosciences (EVFM) Stock: $0.53 Price Target And Underweight Rating |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for EVFM

HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround
TEL AVIV, Israel, July 01, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), today announced that it has acquired certain senior subordinated convertible notes and purchase rights of Evofem Biosciences, Inc. (OTCMKTS: EVFM) (“Evofem”), funded entirely with HUB equity at no cash cost to the Company.
GlobeNewsWire • Jul 1, 2026
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVFM.
U.S. House Trading
No House trades found for EVFM.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
